<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR117">
 <label>117.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Talbot</surname>
    <given-names>HK</given-names>
   </name>
   <name>
    <surname>Rock</surname>
    <given-names>MT</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Tussey</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Kavita</surname>
    <given-names>U</given-names>
   </name>
   <name>
    <surname>Shanker</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Shaw</surname>
    <given-names>AR</given-names>
   </name>
   <name>
    <surname>Taylor</surname>
    <given-names>DN</given-names>
   </name>
  </person-group>
  <article-title>Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin</article-title>
  <source>PLoS One</source>
  <year>2010</year>
  <volume>5</volume>
  <issue>12</issue>
  <fpage>e14442</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0014442</pub-id>
  <?supplied-pmid 21203437?>
  <pub-id pub-id-type="pmid">21203437</pub-id>
 </element-citation>
</ref>
